Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for IMNN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 4.666M
March 31, 2026 3.923M
December 31, 2025 3.420M
September 30, 2025 2.896M
June 30, 2025 1.975M
March 31, 2025 14.62M
December 31, 2024 14.50M
September 30, 2024 14.50M
June 30, 2024 9.401M
March 31, 2024 9.401M
December 31, 2023 9.400M
September 30, 2023 9.368M
June 30, 2023 9.252M
March 31, 2023 9.097M
December 31, 2022 7.436M
September 30, 2022 7.099M
June 30, 2022 7.099M
March 31, 2022 5.770M
December 31, 2021 0.3847M
September 30, 2021 5.770M
June 30, 2021 5.770M
March 31, 2021 5.001M
December 31, 2020 2.713M
September 30, 2020 2.411M
June 30, 2020 2.215M
Date Value
March 31, 2020 1.950M
December 31, 2019 1.550M
September 30, 2019 1.467M
June 30, 2019 1.400M
March 31, 2019 1.311M
December 31, 2018 1.256M
September 30, 2018 1.194M
June 30, 2018 1.183M
March 31, 2018 1.183M
December 31, 2017 1.152M
September 30, 2017 0.557M
June 30, 2017 0.3943M
March 31, 2017 0.2641M
December 31, 2016 0.1487M
September 30, 2016 0.1241M
June 30, 2016 0.1228M
March 31, 2016 0.1115M
December 31, 2015 0.0085M
September 30, 2015 0.1097M
June 30, 2015 0.1096M
March 31, 2015 0.0952M
December 31, 2014 0.0952M
September 30, 2014 0.0951M
June 30, 2014 0.095M
March 31, 2014 0.082M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Phio Pharmaceuticals Corp. 11.62M
Agenus, Inc. 42.62M
Amgen, Inc. 540.60M
Anika Therapeutics, Inc. 13.38M
BioCryst Pharmaceuticals, Inc. 255.26M